Romidepsin Plus 3BNC117 Phase 2a Study

NCT02850016 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Human Immunodeficiency Virus (HIV)

Interventions

DRUG: 3BNC117
DRUG: Romidepsin

Sponsor

Rockefeller University

Collaborators

[object Object]
[object Object]